Meridia Fatality Rate “Substantially Lower” Than Obese Population – Abbott

Abbott's Meridia patient fatality rate is "substantially lower" than what would generally be expected from the obese population, the company maintains in response to a Public Citizen Health Research Group petition calling for the drug's withdrawal

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet